Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech polymer materials.
Bayer is a world-class innovation company with a 150-year history. Our scientific successes are intended to help improve people’s lives.
With our distinctive knowledge of people, animals, plants and materials, we intend to focus in future on the areas of health care, nutrition and high-tech polymer materials.
Read more about our economic, ecological and social challenges and opportunities.
This area provides news, videos and publications, as well as overviews of social media channels and mobile apps of the Bayer Group.
We want to create value for our shareholders through innovation, growth and high earning power.
Looking for a job in an innovative company? Learn more about Bayer and the opportunities available.
Location: Leverkusen, BayKomm (Bayer‘s Communication Center)
Dr. Marijn Dekkers, CEO of Bayer AG
Johannes Dietsch, CFO of Bayer AG
Group portfolio to focus on Life Sciences / All subgroups contribute to record sales and earnings / Recently launched products drive growth momentum / Group sales EUR 42,239 million (plus 5.2 percent / Fx & portfolio adj. plus 7.2 percent) / EBIT advances by 11.6 percent to EUR 5,506 million / EBITDA before special items up by 4.9 percent to EUR 8,812 million / Net income increases 7.4 percent to EUR 3,426 million / Core earnings per share up 7.3 percent to EUR 6.02 / Forecast for 2015: further sales growth and clear improvement in earnings more
Annual Report 2014
Recording (dubbed into English):
Follow our social media channels throughout the day to get regular updates on the full year 2014 results of Bayer AG:
Facebook We invite you to become part of our community and to discuss the full year 2014 results of Bayer AG on » Facebook
Friday, March 27, 2015
Planned publication of the notice of the meeting and agenda of the Annual Stockholders’ Meeting 2015